Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

New review urges proteostatic fitness standards for stem cell therapies

Stem cell therapies have expanded rapidly, with more than 115 clinical trials involving over 1,200 patients approved by late 2024. The U.S. Food and Drug Administration (FDA) recently approved Ryoncil (remestemcel‑L) for children with steroid‑refractory acute graft‑versus‑host disease, signaling a major shift toward routine clinical use.

11 Aug 2026

New research agreement funds xenoliver transplant center at Baylor

Baylor College of Medicine today announced that a new research agreement with United Therapeutics Corporation, a public benefit corporation, will provide up to $5 million a year for five years to establish the Baylor College of Medicine Center for Xenoliver Transplantation and Immunomodulation (XTI), dedicated to advancing scientific understanding of xenoliver transplantation.

10 Aug 2026

Accelerating life science computing with AI-ready infrastructure

Discover how computing is transforming life science research through AI infrastructure, GPU acceleration, and genomics.

From Advantech 10 Aug 2026

Study finds more than half of mapped US parks lie near toxic chemical-reporting facilities

A nationwide geospatial analysis of 151,366 publicly accessible parks found that 52.6% lay within two miles of at least one industrial facility reporting toxic chemical management to the EPA, while 17.7% had parkland within two miles of a current or former Superfund site. The study mapped proximity rather than contamination or exposure, highlighting locations where targeted environmental assessment and healthier urban planning may be warranted.

9 Aug 2026

Integrated nanomaterials offer new strategies for cancer immunotherapy

Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not achieve lasting benefit.

9 Aug 2026

Targeted dendritic cell vaccines emerge as a major step forward in cancer immunotherapy

A major step forward in cancer immunotherapy is emerging through the growing development of dendritic cell vaccines, a highly targeted approach designed to harness the body's own immune system to fight tumors.

5 Aug 2026

Artificial cells offer new insights into living cell behavior

Using simple artificial cells, a research group led by Makito Miyazaki of the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have uncovered fundamental physical principles that govern how living cells change their shape.

5 Aug 2026

New 3D brain tissue model accelerates Alzheimer's drug development

How can Alzheimer's research be made faster, better, and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully arrest the progress of the disease.

4 Aug 2026

DNA Script and leading healthcare solutions provider awarded up to $26 M by ARPA-H to advance cell-free DNA bioproduction

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million in funding for a four-year initiative from the Advanced Research Projects Agency for Health (ARPA-H).

From DNA Script 4 Aug 2026

RNA-based therapeutic strategy targets brain pathway behind cancer-associated cachexia

A new path has opened toward stopping cancer-associated cachexia, a devastating complication that gradually wastes patients away.

2 Aug 2026

New stem cell vesicles accelerate diabetic wound healing

Diabetic foot ulcers are among the most serious complications of diabetes because prolonged inflammation, poor circulation, and defective angiogenesis can leave wounds open for months and increase the risk of infection and amputation.

31 Jul 2026

Sino Biological launches SuperNuclease® Pro with free trial program

Sino Biological, Inc., a global leader in recombinant technology, announced the launch of SuperNuclease® Pro (Cat#: SSNP02).

From Sino Biological Inc. 31 Jul 2026

Scientists develop a promising way to create new antifungal drug candidates

Scientists at Imperial College London and The University of Manchester have developed a promising new way to create safer and more effective treatments for life-threatening fungal infections.

29 Jul 2026

Immature NK cells in donor cord blood can undermine CAR NK cell therapy activity

The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies.

29 Jul 2026

Harvard bioengineers develop a way to quickly create customizable blood vessel grafts

Traumatic injuries, whether on a battlefield or in a car accident, often involve damaged blood vessels that require immediate repair.

29 Jul 2026

How real-time off-gas analysis improves fermentation process control

Real-time off-gas analysis helps optimize fermentation by improving process control, reducing failed batches and supporting faster development.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 29 Jul 2026

New antimicrobials could help tackle deadly drug-resistant infections

Scientists at Imperial College London and The University of Manchester have developed a promising new way to create safer and more effective treatments for life-threatening fungal infections.

29 Jul 2026

Emerging non-endocytic transmembrane delivery strategies for precision medicine

Conventional endocytosis-mediated delivery is limited by poor endosomal escape efficiency, making intracellular delivery of therapeutic biomacromolecules a long-standing challenge in modern biomedical research.

24 Jul 2026

New bacterial control strategy helps revive failing last-line antibiotics

Antimicrobial resistance is one of the world's most alarming public health challenges, because the multidrug-resistant (MDR) gram-negative bacteria increasingly render even last-line antibiotics ineffective, leading to substantially higher mortality rates.

23 Jul 2026

TriLink BioTechnologies® further strengthens global IP position with newly issued patent in China for CleanCap® capping technology

TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 11246578.X, covering methods of synthesizing RNA molecules.

From TriLink Biotechnologies 23 Jul 2026

Manufacturing News and Research

Further Reading

New review urges proteostatic fitness standards for stem cell therapies

New research agreement funds xenoliver transplant center at Baylor

Accelerating life science computing with AI-ready infrastructure

Study finds more than half of mapped US parks lie near toxic chemical-reporting facilities

Integrated nanomaterials offer new strategies for cancer immunotherapy

Targeted dendritic cell vaccines emerge as a major step forward in cancer immunotherapy

Artificial cells offer new insights into living cell behavior

New 3D brain tissue model accelerates Alzheimer's drug development

DNA Script and leading healthcare solutions provider awarded up to $26 M by ARPA-H to advance cell-free DNA bioproduction

RNA-based therapeutic strategy targets brain pathway behind cancer-associated cachexia

New stem cell vesicles accelerate diabetic wound healing

Sino Biological launches SuperNuclease® Pro with free trial program

Scientists develop a promising way to create new antifungal drug candidates

Immature NK cells in donor cord blood can undermine CAR NK cell therapy activity

Harvard bioengineers develop a way to quickly create customizable blood vessel grafts

How real-time off-gas analysis improves fermentation process control

New antimicrobials could help tackle deadly drug-resistant infections

Emerging non-endocytic transmembrane delivery strategies for precision medicine

New bacterial control strategy helps revive failing last-line antibiotics

TriLink BioTechnologies® further strengthens global IP position with newly issued patent in China for CleanCap® capping technology

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy